{"brief_title": "Effects of ONO-2506PO in Patients With Alzheimer's Disease", "brief_summary": "The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.", "condition": "Alzheimer's Disease", "intervention_type": "Drug", "intervention_name": "ONO-2506PO", "criteria": "Inclusion Criteria: - Diagnosis of probable Alzheimer's Disease using NINCDS/ADRDA criteria - Standardized MMSE Score of 13 to 24 points (inclusive) - Modified Hachinski score equal or less than 4 Exclusion Criteria: - Serious systemic disease that may preclude survival to study completion - Other illnesses that may include dementive features", "gender": "All", "minimum_age": "50 Years", "maximum_age": "90 Years", "healthy_volunteers": "No", "id": "NCT00083421.xml"}